Skip to content
healthcare.dev
Get a free key

Mounjaro

NDC 0002-2340, tirzepatide, injection, solution, from Eli Lilly and Company.

Product NDC
0002-2340
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215866
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2340 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIRZEPATIDE10 mg/.5mL

Pharmacologic classes

G-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

Package NDCNDC-11Package
0002-2340-01000022340011 VIAL, SINGLE-DOSE in 1 CARTON (0002-2340-01) / .5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2d7da5d-ad07-4228-955f-cf7e355c8cc0

Use it

Look up 0002-2340 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2340 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-2340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.